To compare the arterial and venous detection sites of triggering methods in contrast-enhanced-MR-venography (CE-MRV) for the evaluation of intracranial venous system.
Original Article
venous structures between different detection sites have not been reported, to our knowledge.
The purpose of this study was to compare the arterial and venous detection sites of venous triggering methods in CE-MRV for the evaluation of intracranial venous system. This retrospective study was approved by our Institutional Review Board for Health Insurance Portability and Accountability Act-compliant study and the need of consent was waivered.
Patient population
Our study population consisted of 41 consecutive patients (22 men and 19 women, 29 to 86 years old, mean age 54 years), who underwent brain MR imaging for health checkup. None of the patients had signs or symptoms suggesting pathologic changes of the cerebral veins or dural sinuses. The CE-MRV were taken by either arterial triggering (n=20) or venous triggering (n=21). Exclusion criterias included nondiagnostic CR-MRV due to severe motion artifact (n=1) and pathological conditions which could alter venous imaging (n=1, incidentally detected parasagittal meningioma). A total of 39 patients (19 arterial triggering and 20 venous triggering CE-MRV) were evaluated.
MRV protocol
All contrast-enhanced-MR-venography (CE-MRV) were performed using a 1.5T MR system (SignaTwinspeed � , GE Medical Systems, Milwaukee, WI, U.S.A.) with a standard head-coil. The sequence of the CE-MRV included the following four integral parts as described by Farb et al. (2) : (a) Initiation of two-dimensional (2D) single-section bolus-detection sequence; (b) Intravenous bolus injection of contrast media; (c) Automated detection of the arrival of intravascular contrast material, resulting in automatic termination of the detection sequence; and trigerring of (d) a fast 3-dimensional gradient-echo MR angiography sequence with elliptic centric-ordered phase encoding.
The 2D real-time fluoroscopic bolus-detection sequence was used to trigger 2D MR venography (2, 13), which was performed with TR / TE, 11.5 / 9.5; flip angle, 30degree; field of view, 22 × 22 cm; matrix, 320 × 128; bandwidth, 62.5 kHz; and section thickness 10 mm. 2D bolus-detection sequence was oriented in the transverse plane and located at the level of cavernous carotid arteries for the arterial triggering method, and in the sagittal plane, at the superior sagittal sinus for venous triggering method. For bolus detection method, data from the region of interest were collected and evaluated in an automated fashion so that the mean signal intensity of the brightest 20% of pixels in the region of interest was averaged for 10 consecutive images. These protocols were provided by our MR vendor. A triggering threshold was then set at 5 SDs higher than the mean of the averaged data. After the operator was notified that the triggering threshold had been determined, subsequent intravenous injection of a bolus of contrast material resulted in a rapid increase in signal intensity in the region of interest that exceeded the set threshold. After an additional preprogrammed delay of 6 seconds, the detection sequence was terminated automatically and, simultaneously, the 3D centric MR angiographic sequence was initiated. The 6-second delay was determined empirically to ensure sufficient perfusion of contrast material through the circle of Willis, the physiologic cerebral circuit, and well into the intracranial venous system before initiation of the centric filling of k space. With imaging and processing delays, triggering occurred 6-7 seconds after arrival of the leading edge of the bolus of contrast material. Bolus of 0.1 mmol/kg of gadolinium-based contrast material (Magnevist � , Schering, Germany) was intravenous injected by hand injection at the rate of 2 cc/sec, followed by injection of 20 cc of saline at the same rate. This injection protocol was followed for all patients. A sagittal fast-spoiled-gradient-echo-sequence ranging from one ear to the other ear was performed using the following parameters: TR/TE, 5.2/1.5; flip angle, 30 ; fractional echo acquisition; field of view, 25 cm; matrix, 320 × 320; bandwidth, 62.5 kHz; section thickness, 1.2 mm; 124 partitions, resulting voxel dimensions were 0.78 × 0.78 × 1.2 mm.
Image analysis
Two radiologists (K.B.S. and J.S.L., each with over 10 years of experience) interpreted the MIP images of arterial triggering CE-MRV and venous triggering CE-MRV studies, in random order, on a dedicated PACS
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station (Marosis m-view
� ; Infinitt, Seoul, Korea), blinded of patient history and identity. Readers were blinded to the different MRV techniques. Separate image reading sessions were organized for both readers by the study coordinator (C.H.S.), who attended all reading sessions. The readers were instructed to use the only coronal and sagittal MIP postprocessed data. Both the arterial triggering CE-MRV and venous triggering CE-MRV were evaluated qualitatively for image quality. Each MRV data set was divided into 17 predefined intracranial venous structures: the superior, inferior sagittal sinus, right and left transverse sinus, transverse sigmoid sinus junction, sigmoid sinus, thalamostriate veins, internal cerebral veins, vein of Galen, basal veins of Rosenthal, and the straight sinus. A total of 663 venous structures were analyzed during both arterial triggering CE-MRV and venous triggering CE-MRV.
Overall image quality was rated using a three -point scale: 1 = not visible, 2 = partially visible, 3 = completely visible. A completely visible structure implied that the reader was highly confident that he/she was able to visualize the lumen of the venous structure in its entirety, whether it was truly hypoplastic or clearly normal. With these criteria, the readers were not permitted to designate a dural venous sinus as simply hypoplastic as a justification for a report of partially visible or not visible. The readers were also asked to assess the overall quality of the MR venograms as diagnostic or nondiagnostic.
When two radiologists rated image quality differently, the final score of image quality was made with a b consensus.
Statistics
The Student's t test or Mann-Whitney U test, depending on the results of a normality (KolmogorovSmirnov) test, was used to compare the patient's sex, age, past medical history between the two groups.
The image quality scores between the arterial triggering CE-MRV and venous triggering CE-MRV were compared with the Fisher exact test.
For interobserver agreement, the kappa value was calculated. Interobserver agreement for the image quality on each dataset, and for detection of findings on each dataset between the two readers, were determined by calculating the k values, using a weighted kappa test (poor agreement k = 0; slight agreement k = 0.01-0.2, fair agreement k = 0.21-0.4; moderate agreement k = 0.41-0.6; good agreement k =0.61-0.8; excellent agreement k = 0.81-1). P < 0.05 were regarded as statistically significant. There was no significant difference in the patient's sex, age, past medical history between the arterial triggering CE-MRV group (n=19) and venous triggering CE-MRV group (n=20).
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The overall image quality scores rated by both readers for the arterial triggering CE-MRV and venous triggering CE-MRV were all in the visibility range, with the mean image quality scores as 2.83 (CI = 2.78-2.87) for the arterial triggering CE-MRV and 2.89 (CI = 2.86-2.93) for the venous triggering CE-MRV. The rate of completely visible venous structures were 272 out of 323 (84%) in the arterial triggering CE-MRV ( Fig. 1 ) and 310 out of 340 (91%) in the venous triggering CE-MRV (Fig. 2) ( Table 1 ). The overall score was significantly higher in the venous CE-MRV group compared to the arterial triggering CE-MRV group (p < 0.006).
Interobserver agreements was good for both for arterial triggering CE-MRV (k = 0.76) and venous triggering CE-MRV (k = 0.72).
The mean triggering time (time taken for the contrast media to exceed the level of triggering concentration at the detected site) was measured 19.4 sec (13-28 sec) in arterial triggering CE-MRV and 21.0 sec (17-36 sec) in venous triggering CE-MRV (Table 2) .
MR venography is regarded as the best noninvasive method for evaluating the cerebral venous system (13) . The two most common techniques are time-offlight effects of moving spins and motion-induced phase shifts (the 3D phase-contrast technique). Phasecontrast MRV uses velocity-induced phase shifts, which are proportional to the velocity of flow, to depict flowing blood. Phase-contrast MRV has the ability to quantify flow and determine flow direction. CE-MR angiography technique benefits from a triggering mechanism to optimize capture of vascular contrast with the acquisition of raw data corresponding to the center of the k-space collected during the contrast material in the vessel of interest. Accurate timing of the arrival of the contrast material bolus to the acquisition of the central k-space lines is critical to the success of this technique (14, 15) . The transit time of a contrast material bolus from the infusion site to the imaged region of the body varies with heart rate, cardiac output, age, and severity of the vascular abnormality, which are parameters difficult to predict accurately. Liauw et al. conducted a study in 12 healthy volunteers using time-of-flight and phasecontrast techniques in the transverse, sagittal, and coronal planes. They found that visualization of a normal intracranial venous system was better with 3D phase-contrast and 2D time-of-flight MR angiographic techniques in the coronal plane than with transverse or sagittal 2D time-of-flight MR angiography (16) . CE-MRV with the paramagnetic effect of gadolinium shortens the intravascular T1 relaxation time, thus increasing the signal intensity of blood, with no saturation effects. For optimal image quality, the injection profile must be set when the contrast bolus is maximally present within the vessels of interest during image acquisition. Too early or too late acquisition might miss the peak passage of contrast bolus and produce inadequate visualization of the vessels. The major advantages of 3D CE-MRV are the superior visualization of intracranial venous morphology, and a faster acquisition time which reduces patient-related motion artifacts on the images (17) . There are several methods to detect and trigger the optimal timing for contrast injection during image acquisition of 3D CE-MRV. There have also been many reports comparing 3D CE-MRV with time-offlight or phase-contrast MRV (5-7, 10). Fu et al have successfully used a real-time triggering method, in which the 3D CE MR angiographic sequence was initiated precisely when contrast medium was filling in the superior sagittal sinus (18) . Farb et al compared Auto-triggered elliptic centric ordered sequence (ATECO) MR venography with inserted time-delay after arterial triggering and time-of-flight MR venography techniques in 23 patients and observed rates of complete visibility of the venous structure of 99% and 72%, respectively (17) .
DISCUSSION

RESULTS
Our study revealed a significantly higher image quality of the intracranial venous structures in the MR venography conducted with venous triggering method compared to the arterial triggering method. The difference between the triggering time of the arterial and venous CE-MRV was about two seconds (ranging from four to eight seconds). We suggest this difference may have arised from the circulation time between the carotid artery and internal jugular vein, and is somewhat similar to the reported cerebral circulation time, which is 5.54 seconds when measured by sonogram (19) . Our results also demonstrated the triggering time also varied between the same methods (13-28 sec in arterial triggering CE-MRV and 17-36 sec in venous triggering CE-MRV), even though all the included patients had no pathologic conditions. The circulation time may probably vary even more in pathologic conditions, again suggesting the benefit of individualized triggering methods compared to the standard delayed method. However caution in using venous triggering method in patients with venous thrombosis is needed because the contrast media may have a very long triggering time or even never exceed the triggering point due to complete obstruction.
The followings are some limitations of our study. The major limitation of our study lies in its small size and retrospective nature. The study population was not constant because of continuous influx and efflux of patient. To overcome this as much as possible, we used consecutive normal patients. Also, the intra individual comparison of arterial triggering and venous triggering MR venography could not be done for the same patients due to obvious ethical reasons. However, we believe that this shortcoming has been overcome, because the patient's sex, age, past medical history were compared and were not significantly different between the two groups. Furthermore, the study was based on nonpathological patients only. Thus, one must be careful to applicate these results on patients with pathological conditions of the venous system. Future studies on the triggering detection site and time of venous pathology, such as venous thrombosis should be done.
In conclusion, venous triggering contrast enhanced MR venography provides high-quality images of the intracranial venous structures superior to that of arterial triggering contrast-enhanced MR venography. Further studies are required to determine the utility of the technique in neurovascular diseases such as dural venous sinus thrombosis.
